Yonggui G. Hong
Anyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Integrative management of gastric cardia cancer and precancerous lesions: prospects and mechanistic rationale for Banxia Xiexin Tang.
Journal: Frontiers in pharmacology
Published: December 08, 2025
Advances in the mechanisms underlying the contributions of thymocyte selection-associated high mobility group box to pathogen infections: a review
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: December 02, 2025
On-target/off-tumor toxicities following infusion of low-affinity Nectin-4-specific CAR T cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 10, 2025
Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.
Journal: Molecular cancer
Published: January 25, 2025
First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study.
Journal: Signal transduction and targeted therapy
Published: June 03, 2024
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 02, 2024
Feasibility and tolerability of anlotinib plus PD-1 blockades as rechallenge immunotherapy in previously treated advanced ESCC: a retrospective study.
Journal: The oncologist
Published: May 31, 2024
Epidemic trend and control progress of taeniasis and cysticercosis in Henan Province
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: December 04, 2022
Evaluation of efficiency of different anti-cysticercus antibody test kits for serodiagnosis of cysticercosis
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: March 10, 2022
Effectiveness of training on Taenia solium taeniasis and cysticercosis control knowledge among medical professionals in disease-elimination pilot areas of Henan Province
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: February 07, 2022
Effectiveness of health education interventions targeting taeniasis and cysticercosis among primary school students in disease-elimination pilot areas of Henan Province
Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Published: February 07, 2022
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: August 19, 2021
Last Updated: 09/26/2026